EFNB2 and Cerebral ischemia: We speculated that PB-MNC from type-2 diabetic patients, stimulated by ephrin-B2 (PB-MNC+) and transplanted into mice 18–24 hours after induction of experimental cerebral ischemia, would be more effective than PBS or unstimulated PB-MNC in promoting stroke recovery.